STON2 and ovarian carcinoma: A survival analysis revealed that the cumulative overall survival (OS) and disease-free survival (DFS) rates of ovarian cancer patients decreased with increase in STON2 protein expression (Figure 4), indicating that STON2 overexpression was associated with poor overall survival and survival with a high recurrence rate.